Graciela Nogueras González

Statistics

Publications

Citations

1.1K

H-Index

Active since

2015

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of California, Irvine Medical Center

Cancer Research And Biostatistics

Graciela Nogueras González is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, hematology, and hematologic oncology.

Publications per year

2015–2020

Publications

Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience

Kamal Chamoun, Hagop M. Kantarjian, Rami Atallah et al. · Journal of Hematology & Oncology · 2019 · 176 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients

Preetesh Jain, Hagop M. Kantarjian, Ahmad Ghorab et al. · Cancer · 2017 · 164 citations · Full text

Medicine, Hematology, Oncology +12

Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors

Preetesh Jain, Hagop M. Kantarjian, Keyur P. Patel et al. · Blood · 2016 · 154 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 study

Preetesh Jain, Hagop M. Kantarjian, Elias Jabbour et al. · The Lancet Haematology · 2015 · 106 citations · Full text

Medicine, Hematology, Pharmacology +7

Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia

Koji Sasaki, Rashmi Kanagal‐Shamanna, Guillermo Montalban‐Bravo et al. · Cancer · 2019 · 99 citations

Life Sciences, Genetics, Molecular Genetics +16

1–5 of 14